Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction

Author:

Butt Jawad H.1ORCID,Dewan Pooja2,Merkely Béla3ORCID,Belohlávek Jan4ORCID,Drożdż Jarosław5ORCID,Kitakaze Masafumi6,Inzucchi Silvio E.7,Kosiborod Mikhail N.8,Martinez Felipe A.9,Tereshchenko Sergey10ORCID,Ponikowski Piotr11ORCID,Bengtsson Olof12ORCID,Lindholm Daniel12ORCID,Langkilde Anna Maria12ORCID,Schou Morten13,Sjöstrand Mikaela12,Solomon Scott D.14,Sabatine Marc S.15ORCID,Chiang Chern-En16,Docherty Kieran F.2ORCID,Jhund Pardeep S.2ORCID,Køber Lars17ORCID,McMurray John J.V.2ORCID

Affiliation:

1. British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom, and Department of Cardiology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark (J.H.B.)

2. British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom (P.D., K.F.D., P.S.J., J.J.V.M.)

3. Heart and Vascular Centre, Semmelweis University, Budapest, Hungary (B.M.)

4. Second Department of Internal Medicine, Cardiovascular Medicine, General Teaching Hospital, First Faculty of Medicine, Charles University, Prague, Czech Republic (J.B.)

5. Department of Cardiology, Medical University of Lodz, Lodz, Poland (J.D.)

6. Cardiovascular Division of Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan (M.K.)

7. Section of Endocrinology, Yale School of Medicine, New Haven, Connecticut (S.E.I.)

8. Saint Luke's Mid America Heart Institute, University of Missouri, Kansas City, Missouri, and The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia (M.N.K.)

9. Universidad Nacional de Córdoba, Córdoba, Argentina (F.A.M.)

10. Department of Myocardial Disease and Heart Failure, National Medical Research Center of Cardiology of Russia, Moscow, Russia (S.T.)

11. Center for Heart Diseases, University Hospital, Wroclaw Medical University, Wroclaw, Poland (P.P.)

12. Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (O.B., D.L., A.M.L., M.Sjöstrand)

13. Department of Cardiology, Herlev-Gentofte University Hospital, Herlev, Denmark (M.Schou)

14. Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts (S.D.S.)

15. Division of Cardiovascular Medicine and TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts (M.S.S.)

16. General Clinical Research Center and Division of Cardiology, Taipei Veterans General Hospital and National Yang Ming Chiao Tung University, Taipei, Taiwan (C.C.)

17. Department of Cardiology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark (L.K.).

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3